In this study, we demonstrated that BBD24 not only potently blocks cytoplasm-to-nucleus translocation of NF-κB p65 but also inhibits the activation of AKT and ERK signaling pathways, indicating that BBD24 is a potent inhibitor of multiple cancer-associated signaling pathways. This evidence concerns the gene NFKB1 and cancer.